IPP Bureau
Indian scientists develop AI-enabled tech for biomedical diagnostic applications
By IPP Bureau - May 28, 2026
The platform created by NIT Rourkela researchers is capable of delivering rapid, accurate, and repeatable imaging results with minimal human intervention
Remidio’s InstaEyeClinic wins first position at Andhra Pradesh MedTech Innovation Challenge
By IPP Bureau - May 28, 2026
The device screens for conditions like diabetic retinopathy, glaucoma, age-related macular degeneration, cataract and refractive error, in under ten minutes per patient
Cadila Pharma launches Subhadra Syrup for menstrual health support
By IPP Bureau - May 28, 2026
The syrup launched by company's Chezgreen division is designed to provide supportive care in managing common menstrual concerns such as amenorrhea, dysmenorrhea, and menorrhagia
Teen neuroscience researcher turns ADHD struggles into startup innovation
By IPP Bureau - May 28, 2026
Adya Anubhuti launches ADHD Copilot, an AI-powered platform designed to reduce stress and mental overload
Asahi Kasei bags breakthrough ADC tech in push for safer & more precise cancer therapies
By IPP Bureau - May 28, 2026
The newly licensed platform enables precise control over both the drug-to-antibody ratio and payload attachment sites in single- and dual-payload ADCs
Hikal swings back to profit in Q4 FY26 despite regulatory hit & strategic charges
By IPP Bureau - May 28, 2026
Hikal’s Q4 profit remained sharply lower year-on-year, falling 71% from Rs. 50.2 crore in Q4 FY25 as the company absorbed regulatory pressures and strategic accounting adjustments
Novo Nordisk to showcase late-stage pipeline & semaglutide expansion at ADA 2026
By IPP Bureau - May 28, 2026
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
Supriya Lifescience posts 50% revenue growth in Q4 FY26; PAT rises to Rs 74 crore
By IPP Bureau - May 28, 2026
On a full-year basis, revenue from operations for FY26 grew 18.9 percent year-on-year to Rs 827.87 crore compared to Rs 696.48 crore in FY25
Lupin’s Ankleshwar facility receives EIR from U.S. FDA
By IPP Bureau - May 28, 2026
The Establishment Inspection Report came following closure of a product- specific pre-approval inspection from March 2 to March 7, 2026
Organ Man of India Nilesh Mandlewala bestowed with Padma Shri
By IPP Bureau - May 28, 2026
Honoured for his immense contribution in the field of social service and organ donation awareness
India’s healthcare spending triples to Rs 3.85 lakh crore over the last decade
By IPP Bureau - May 28, 2026
As per National Health Accounts (NHA) estimates, government health expenditure rose steadily between 2013-14 and 2022-23, while out-of-pocket spending declined significantly
Kyoto–Tokyo consortium launches first-of-its-kind zirconia recycling project for dental waste
By IPP Bureau - May 28, 2026
Under the new initiative, each company takes on a defined role across the recycling chain
Gandhar Oil posts robust FY26 profit
By IPP Bureau - May 28, 2026
PAT soars 201%, EBITDA up 88% on strong PHPO demand & margin expansion
Morepen Labs posts strong Q4 FY26 net profit
By IPP Bureau - May 28, 2026
For the full year, standalone gross revenue crossed Rs. 1,700 crore
Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD
By IPP Bureau - May 28, 2026
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
